StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck access to Health — People Reached with Social Investments (millions)

Merck Impact Report (Access to Health & Social Investments)

Latest, FY2025
15.70
Period ended Dec 31, 2025
Change on a year earlier
+37.7%
11.40 in FY2024
History
5 years
Since FY2021
Sources
1
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccess to Health — People Reached with Social Investments (millions)Year on yearSource
FY2025Dec 31, 202515.70+37.7%–
FY2024Dec 31, 202411.40-46.2%–
FY2023Dec 31, 202321.20+14.0%–
FY2022Dec 31, 202218.60+24.0%–
FY2021Dec 31, 202115.00––

Breakdown

What makes up access to health — people reached with social investments (millions)

Cite this data

StockData. (2026). Merck Access to Health — People Reached with Social Investments (millions), annual FY2021–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/esg_social_reach_m

See every metric in the Merck KPI table. Data updated Oct 26, 2026.